HZD.L Share News (HZD)

HZD.L Information

There is currently no data for HZD

UK DIRECTOR DEALINGS SUMMARY: Crest Nicholson Executives Buy Shares

Fri, 26th Jun 2020 18:08

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

----------

Crest Nicholson Holdings PLC - Chertsey-based residential developer - Director David Marchant buys 8,767 shares at GBP2.26 each for a total of GBP19,813, and an associate Sharon Marchant buys 4,741 shares at GBP2.09 each. Sally Nicholson, associate of Chief Operating Officer Tom Nicholson, buys 22,485 shares at GBP2.21 each on Thursday for a total of GBP49,691. Chair Iain Ferguson buys 10,000 shares at GBP2.18 each for a total of GBP21,800, and an associate of his, Catherine Ferguson, buys 40,000 shares over three transactions at GBP2.12 each on Thursday for a total of GBP84,800.

----------

Urban&Civic PLC- London-based master developer of large land sites - Director Ian Barlow buys 30,000 shares at GBP2.165 each on Friday for a total of GBP64,950.

----------

MITIE Group PLC - Facilities management firm based in Glasgow - Director Phillipa Couttie buys 18,200 shares at 91 pence each on Thursday for a total of GBP16,562.

----------

Transense Technologies PLC - Oxfordshire-based sensor systems maker - Executive Chair Nigel Rogers buys 4,350 shares at 57p each for a total of GBP2,479 and his wife buys 4,350 shares at teh same price for a total of GBP2,479, taking their total stake to 0.7%. Chief Financial Officer Melvyn Segal buys 8,000 shares at 56p each for a total of GBP4,480, taking his stake to 0.2%.

----------

Renishaw PLC - Gloucestershire-based machine tools company - Deputy Chair John Deer sells 10,000 shares at GBP39.05 each for a total of GBP390,500. Also sells an additional 30,000 shares at GBP38.13 each, totalling GBP1.1 million.

----------

Trackwise Designs PLC - Printed circuit boards manufacturer based in Gloucestershire - Chief Financial Officer Mark Hodgkins buys 11,000 shares at 86.85p each for a total of GBP955,350.

----------

Horizon Discovery Group PLC - Cambridge-based cell engineering firm - Non-Executive Chair Ian Gilham buys 25,000 shares at 99p each for a total of GBP24,997 on Thursday. Non-Executive Director Susan Searle buys a total of 15,309 shares over two transactions at GBP1.01 each for a total of GBP15,477.

----------

SDCL Energy Efficiency Income Trust - energy-focused investment firm based in London - Director Jonathan Maxwell buys 30,000 shares at 104p each for a total of GBP31,200. Direcotr Tony Roper buys 15,000 shares at the same price for GBP15,600.

----------

By Ife Taiwo; ifetaiwo@alliancenews.com

More News

25 Jul 2014 13:04

Horizon Discovery awarded £0.8m contract

Research tools provider Horizon Discovery has been contracted by bio medicine group Otsuka Pharmaceutical Development Commercialisation (OPDC) for $0.8m. The Cambridge-based group has been appointed by Otsuka to perform in vitro cell line screening for clinical stage OPDC development candidates. Th

25 Jul 2014 11:38

Horizon Discovery Wins Contract With Otsuka Pharmaceutical Development

23 Jul 2014 09:49

Horizon Discovery Confident On Strong Full-Year On In Line First-Half

3 Jul 2014 09:33

Horizon Inks Intellectual Property Licence Deal With Stanford University

19 Jun 2014 15:58

Premier Foods non-exec makes show of faith

Pam Powell, a non-executive director of Premier Foods, has acquired 74,369 shares in the group one day after it warned that sales of its key brands were set to fall short of expectations this year. Powell paid 53.5p for each of the shares, spending a total of £39,787. The modest show of faith ca

19 Jun 2014 10:35

DIRECTOR DEALINGS: Horizon Discovery CEO Buys 10,000 Shares

LONDON (Alliance News) - Horizon Discovery PLC Thursday said Chief Executive Officer Darrin Disley bought 10,000 shares at a price of 145 pence per share. Following this transaction, Disley's direct beneficial interest is 682,523 shares, representing 1.02% of the total issued share capital.

16 Jun 2014 10:22

Horizon Discovery Gets UK Research Grant For Cancer Diagnostics

LONDON (Alliance News) - Horizon Discovery Group PLC Monday said it has been awarded a GBP360,224 research grant from the UK's Technology Strategy Board, together with life sciences testing firm LGC Ltd to develop standardisation for next-generation cancer diagnostics. Horizon said it will

12 Jun 2014 12:28

Horizon Discovery Licenses Broad Institute's Gene Editing System

LONDON (Alliance News) - Horizon Discovery Group PLC said Thursday it has licensed the Broad Institute's CRISPR/Cas9 gene editing system, which is used to mutate or change genes in living cells. The Broad Institute is a research centre in the US state of Massachusetts, connected with the Ma

11 Jun 2014 15:50

Numis Chief reduces stake with sale of 3m shares

Oliver Hemsley, the Chief Executive Officer of Numis, has traded in three million shares, reducing his stake by almost a quarter to 9.4m. The 270p-a-share disposal generated £8.1m. The sale comes around one month after the group posted a 59% jump in first half revenue at £51.5m. Adjusted pre-t

11 Jun 2014 11:41

DIRECTOR DEALINGS: Horizon Discovery Non-Executive Buys Shares

LONDON (Alliance News) - Life science company Horizon Discovery Group PLC Wednesday said Non-Executive Director Susan Searle purchased 16,000 shares at 159.96 pence per share for her self-invested personal pension fund. Following this transaction, Searle holds 20,000 shares, which represent

15 May 2014 14:02

Horizon Discovery Adds US Screening Business To Portfolio

LONDON (Alliance News) - Horizon Discovery Group PLC, the biotechnology company that listed on AIM earlier this year, Thursday said it had bought the CombinatoRx service business and assets from Zalicus for GBP4.7 million, a deal that will give it a revenue generating screening business supported

8 May 2014 12:53

Horizon Inks Licence Agreement With ERS Genomics For Intellectual Property

LONDON (Alliance News) - Horizon Discovery Group PLC said Thursday that it had entered into a non-exclusive licence agreement to allow ERS Genomics Ltd access to intellectual property relating to its CRISPR/Cas9 gene editing system. Under the agreement, Horizon will be able to use the techn

8 May 2014 09:03

Horizon Discovery signs agreement with Genomics

Biotechnology group Horizon Discovery has entered into a non-exclusive agreement with science research group ERS Genomics to access the group's gene editing system. The company will be allowed to use technology from DR. Emmanuelle Charpentier and her colleagues for a range of research applications.

16 Apr 2014 16:31

Horizon Discovery Says It Has Continued To Trade Strongly Since IPO

LONDON (Alliance News) - Horizon Discovery Group PLC said Wednesday that it had continued to trade strongly since its initial public offering, after its share price closed down 5.8%. The biotechnology company said it had traded "at least in line with expectations", and that it is pursuing i

27 Mar 2014 10:57

Horizon Discovery discovers warm welcome on AIM debut

Shares rose in life science research tools supplier Horizon Discovery on its first day of dealings on Thursday. Cambridge-based Horizon, which has been ranked as one of the fastest growing biotechnology companies in Europe by Deloitte, raised a gross £40m as part of its initial public offering at

Latest Share Chat

HZD.L Share News (HZD)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Crest Nicholson Executives Buy Shares

Login to your account

Quickpicks are a member only feature

Login to your account